Kadoya M, Suganuma N, Matsubara Y, Takase H, Kumagai E, Toda S
Surg Case Rep. 2024; 10(1):92.
PMID: 38647958
PMC: 11035533.
DOI: 10.1186/s40792-024-01898-7.
Qiu P, Guo Q, Pan K, Lin J
BMC Cancer. 2024; 24(1):235.
PMID: 38378515
PMC: 10877775.
DOI: 10.1186/s12885-024-12004-3.
Bi J, Zhang H
Medicine (Baltimore). 2023; 102(50):e36647.
PMID: 38115346
PMC: 10727648.
DOI: 10.1097/MD.0000000000036647.
Zhao M, Shi X, Zhang J, Deng S, Zhou Y, Wen R
Comput Math Methods Med. 2022; 2022:8028846.
PMID: 36110571
PMC: 9470344.
DOI: 10.1155/2022/8028846.
Liang S, Huang K
J Oncol. 2022; 2022:5916379.
PMID: 35356255
PMC: 8959952.
DOI: 10.1155/2022/5916379.
Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
Ye L, Hu L, Liu W, Luo Y, Li Z, Ding Z
BMC Cancer. 2021; 21(1):1250.
PMID: 34800991
PMC: 8605523.
DOI: 10.1186/s12885-021-08875-5.
Radiomics Nomogram for Identifying Sub-1 cm Benign and Malignant Thyroid Lesions.
Wu X, Li J, Mou Y, Yao Y, Cui J, Mao N
Front Oncol. 2021; 11:580886.
PMID: 34164333
PMC: 8215667.
DOI: 10.3389/fonc.2021.580886.
Mixed medullary-papillary thyroid carcinoma with mixed lymph node metastases: A case report.
Guerreiro V, Costa C, Oliveira J, Santos A, Farinha M, Jacome M
Clin Case Rep. 2021; 9(5):e04165.
PMID: 34084509
PMC: 8142802.
DOI: 10.1002/ccr3.4165.
Comprehensive evaluation of risk factors for lymph node metastasis in patients with papillary thyroid carcinoma.
Dong Y, Wang D, Luo Y, Chen L, Bai H, Shen Y
Oncol Lett. 2021; 21(3):188.
PMID: 33574927
PMC: 7816409.
DOI: 10.3892/ol.2021.12449.
Associations of BRAF V600E, clinical pathology and imaging factors with the recurrence rate of papillary thyroid microcarcinoma.
Huang K, Gao N, Bian D, Zhai Q, Yang P, Zhang Y
Exp Ther Med. 2020; 20(6):243.
PMID: 33178341
PMC: 7651867.
DOI: 10.3892/etm.2020.9373.
Population-based study evaluating and predicting the probability of death resulting from thyroid cancer among patients with papillary thyroid microcarcinoma.
Wang K, Xu J, Li S, Liu S, Zhang L
Cancer Med. 2019; 8(16):6977-6985.
PMID: 31588675
PMC: 6853812.
DOI: 10.1002/cam4.2597.
Active surveillance of low-risk papillary thyroid carcinoma: a promising strategy requiring additional evidence.
Ze Y, Zhang X, Shao F, Zhu L, Shen S, Zhu D
J Cancer Res Clin Oncol. 2019; 145(11):2751-2759.
PMID: 31571010
DOI: 10.1007/s00432-019-03021-y.
Does every classical type of well-differentiated thyroid cancer have excellent prognosis? A case series and literature review.
Kaliszewski K
Cancer Manag Res. 2019; 11:2441-2448.
PMID: 31118764
PMC: 6497976.
DOI: 10.2147/CMAR.S198514.
Is hemi-thyroidectomy adequate in low risk differentiated thyroid cancer?.
Benjamin J, Hephzibah J, Cherian A, Mathew D, Shanthly N, Oommen R
World J Nucl Med. 2019; 18(2):171-175.
PMID: 31040749
PMC: 6476241.
DOI: 10.4103/wjnm.WJNM_70_18.
Diagnostic value of high b-value (2000 s/mm2) DWI for thyroid micronodules.
Wang Q, Guo Y, Zhang J, Ning H, Zhang X, Lu Y
Medicine (Baltimore). 2019; 98(10):e14298.
PMID: 30855433
PMC: 6417555.
DOI: 10.1097/MD.0000000000014298.
Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules <10 mm in the maximum diameter: does size matter?.
Lyu Y, Shen F, Yan Y, Situ M, Wu W, Jiang G
Cancer Manag Res. 2019; 11:1231-1236.
PMID: 30799950
PMC: 6369843.
DOI: 10.2147/CMAR.S189358.
Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
Yang F, Zhong Q, Huang Z, Lian M, Fang J
Front Endocrinol (Lausanne). 2019; 10:10.
PMID: 30733707
PMC: 6354565.
DOI: 10.3389/fendo.2019.00010.
Prediction of central lymph node metastasis in papillary thyroid microcarcinoma according to clinicopathologic factors and thyroid nodule sonographic features: a case-control study.
Jin W, Ye D, Sun Y, Zhou X, Wang O, Zhang X
Cancer Manag Res. 2018; 10:3237-3243.
PMID: 30233240
PMC: 6130265.
DOI: 10.2147/CMAR.S169741.
Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation.
Park A, Lee Y, Kim M, Kang Y, Park Y, Jung H
Front Immunol. 2018; 9:1859.
PMID: 30140269
PMC: 6094168.
DOI: 10.3389/fimmu.2018.01859.
Is biopsy enough for papillary thyroid microcarcinoma?: An analysis of the SEER database 2004 to 2013 with propensity score matching.
Liu Z, Zhao Q, Liu C, Zeng W, Ming J, Chen C
Medicine (Baltimore). 2018; 97(31):e11791.
PMID: 30075609
PMC: 6081083.
DOI: 10.1097/MD.0000000000011791.
